Chemed (CHE)
(Delayed Data from NYSE)
$600.06 USD
+4.49 (0.75%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $600.52 +0.46 (0.08%) 5:44 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Revenue - Line of Business Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|
Service revenues and sales: VITAS... |
-- | 1,315 | 1,202 | 1,261 | 1,335 | 1,281 |
Service revenues and sales: Roto-... |
-- | 949 | 933 | 878 | 745 | 657 |
Net Revenue: Medicare cap allowan... |
-- | -8 | -8 | -7 | -7 | -12 |
Income - Line of Business | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
Adjusted EBITDA: Roto-Rooter [$M] |
-- | 270 | 274 | 249 | 193 | 156 |
NFM - Operating & Non Financial Metrics | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
Days of care - Total [#] |
-- | 6,793,832 | 6,324,063 | 6,571,119 | 6,969,504 | -- |
Number of days in relevant time p... |
-- | 365 | 365 | 365 | 366 | -- |
Average daily census (ADC) - Tota... |
-- | 18,613 | 17,325 | 18,003 | 19,042 | 18,846 |